Outcomes Following Limb Sparing Surgery for Soft Tissue Sarcoma

Not yet recruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

May 6, 2025

Primary Completion Date

January 1, 2028

Study Completion Date

January 1, 2028

Conditions
Soft Tissue Sarcoma
Interventions
PROCEDURE

Surgical resection with or without radiotherapy and/or chemotherapy

The surgical resection of STS serves as the primary treatment, aiming to completely remove the tumor with a wide margin of surrounding healthy tissue to minimize the risk of recurrence. Radiotherapy and/or chemotherapy may be incorporated depending on the tumor's type, stage, and grade.

All Listed Sponsors
lead

Amsterdam UMC

OTHER

NCT06962072 - Outcomes Following Limb Sparing Surgery for Soft Tissue Sarcoma | Biotech Hunter | Biotech Hunter